Other studies have successfully implemented anti-tumor gene therapy using the Ad OV platform to deliver a tumor suppressor gene, TSLC1, which is lost in many human cancers, including liver cancers, and conserved in normal cells [33]. Here, CADM1 is linked to neoplasm.